Related references
Note: Only part of the references are listed.Persistence of rT-PCR-SARS-CoV-2 infection and delayed serological response, as a possible effect of rituximab according to the hypothesis of Schulze-Koops et al
Maurizio Benucci et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab
Hendrik Schulze-Koops et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Victor M. Corman et al.
EUROSURVEILLANCE (2020)
Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
Paloma Montero-Escribano et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Convalescent plasma therapy for B-cell-depleted patients with protracted COVID-19
Thomas Hueso et al.
BLOOD (2020)
B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand?
Puja Mehta et al.
LANCET RHEUMATOLOGY (2020)